Last reviewed · How we verify
NCT06625697
Mindfulness Training and Respiration Biosignal Feedback - Study 1
NA trial testing Mindfulness Meditation in Psychological Distress in 80 participants. Completed in 8 August 2025.
8 August 2025
Quick facts
| Lead sponsor | Equa Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 80 |
| Start date | 1 May 2024 |
| Primary completion | 8 August 2025 |
| Estimated completion | 8 August 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mindfulness Meditation
Conditions studied
- Psychological Distress — all drugs for Psychological Distress →
- Develop a Respiration Biosignal Feedback Algorithm — all drugs for Develop a Respiration Biosignal Feedback Algorithm →
- Utilize Respiration Algorithm to Predict Mindfulness Skills — all drugs for Utilize Respiration Algorithm to Predict Mindfulness Skills →
Sponsor
Equa Health
Who can join
Adults 18 to 30, any sex, with Psychological Distress or Develop a Respiration Biosignal Feedback Algorithm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this research is to develop a new breathing feature on the meditation app, Equa, to help young adults who are distressed, understand their physiological responses and mindfulness skill development during meditation. Our main aims are to build an algorithm that can use physiologic signals to: * Give feedback about how participant physiology is changing during guided lessons on the meditation app, Equa * Measure how much participant mindfulness skills are improving Participants will: * Complete a survey about demographics, their thoughts and feelings before and after the mindfulness meditation program * Complete 14 smartphone guided mindfulness meditation training units while physiological measures are being recorded * Complete a few brief questionnaires before and after mindfulness practices to understand potential changes in their mindfulness skills
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06625697
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Meditation
Trials testing the same drug.
- NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting
- NCT06957743 — Mechanisms of Mindfulness Meditation and Self-Hypnosis for Pain in Older Adults With Chronic Pain · NA · not yet recruiting
- NCT06936293 — Effects of Mindfulness Meditation on Hemodialysis Patients · NA · completed
- NCT06175208 — Targeting Fear of Cancer Recurrence in Cancer Survivors: Evaluation of Internet-Based Emotional Freedom Techniques and I · NA · enrolling by invitation
- NCT06095687 — Mind-body Therapies for Injury-related Pain Management in Elite Athletes · NA · withdrawn
Other recruiting trials for Psychological Distress
Currently open trials in the same condition.
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07335302 — CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA Removal · recruiting
- NCT07447089 — EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study · NA · recruiting
- NCT07214428 — Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06625697 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Equa Health
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06625697.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing